from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0887c/-

LFCtreatmentdescriptionclass of inhibitor

0.684

Amikacinug/mL Amikacintranslation

0.006

Cap5-10ug/mL Capreomycintranslation

0.176

Rox10-50 ug/mL Roxithromycintranslation

0.104

SM2-5 ug/mL Streptomycintranslation

0.330

Tet5-10 ug/mL Tetracyclinetranslation

-0.007

Rif0.2-5ug/mL Rifampicintranscription

-0.379

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.196

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

2.139

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.266

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.966

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.518

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.865

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.718

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.931

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-1.417

Econazole10-24 ug/mL Econazole (azole drug)respiration

-2.164

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.324

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.392

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.639

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.569

KCN5-20 ug/mL Potassium cyaniderespiration

-0.636

NaN30.2-2 mM Sodium aziderespiration

0.248

Nigericin50 uM Nigericinrespiration

0.533

TRC10-150 ug/mL Triclosanrespiration

-0.278

TRZ10-25 ug/mL Thioridazinerespiration

3.635

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.939

menadione6-10 ug/mL Menadionerespiration

-0.170

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.318

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.576

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.112

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.492

NRP_1Non-replicating persistence stage 1dosRassociated

-0.221

Amp0.2mg/mL AmpicillincellWall

0.060

Cephalexin20-100 ug/mL CephalexincellWall

-0.323

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.048

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.422

EMB10-20 ug/mL EthambutolcellWall

0.175

Eta12-40 ug/mL EthionamidecellWall

0.162

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.083

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.155

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.156

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.009

BZA0.12 mg/mL BenzamidearomaticAmides

0.001

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.604

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.402

H2O24 mM hydrogen peroxideDNAdamaging

0.600

Levo10 ug/mL LevofloxacinDNAdamaging

-0.550

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.259

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.817

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.336

UVUV-irradiationDNAdamaging

-0.539

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.343

Antimycin12.5-50 ug/mL Antimycin A?

-0.340

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.560

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.364

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.751

PA8240.2-2 ug/mL PA-824?

0.297

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.522

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.000

Verapamil50 uM Verapamil?

-0.285

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.347

methoxatin10-20 ug/mL Methoxatin?